2.24
price up icon1.82%   0.04
pre-market  Pre-mercato:  2.20   -0.04   -1.79%
loading
Precedente Chiudi:
$2.20
Aprire:
$2.19
Volume 24 ore:
527.85K
Relative Volume:
0.71
Capitalizzazione di mercato:
$126.75M
Reddito:
-
Utile/perdita netta:
$-82.44M
Rapporto P/E:
-1.1915
EPS:
-1.88
Flusso di cassa netto:
$-66.75M
1 W Prestazione:
-0.44%
1M Prestazione:
+0.90%
6M Prestazione:
-61.04%
1 anno Prestazione:
-18.84%
Intervallo 1D:
Value
$2.10
$2.2599
Intervallo di 1 settimana:
Value
$2.0208
$2.33
Portata 52W:
Value
$1.91
$7.66

Black Diamond Therapeutics Inc Stock (BDTX) Company Profile

Name
Nome
Black Diamond Therapeutics Inc
Name
Telefono
617-417-5868
Name
Indirizzo
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
Name
Dipendente
54
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
BDTX's Discussions on Twitter

Confronta BDTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
BDTX
Black Diamond Therapeutics Inc
2.24 126.75M 0 -82.44M -66.75M -1.88
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-07-31 Iniziato Raymond James Outperform
2023-07-14 Iniziato Piper Sandler Overweight
2023-06-30 Aggiornamento Stifel Hold → Buy
2023-06-28 Aggiornamento H.C. Wainwright Neutral → Buy
2023-06-27 Aggiornamento Wedbush Neutral → Outperform
2022-03-29 Downgrade Wedbush Outperform → Neutral
2022-03-22 Downgrade H.C. Wainwright Buy → Neutral
2021-09-30 Iniziato Stifel Hold
2021-01-07 Iniziato Wedbush Outperform
2020-11-24 Iniziato Berenberg Buy
2020-05-04 Iniziato H.C. Wainwright Buy
2020-02-24 Iniziato Canaccord Genuity Buy
2020-02-24 Iniziato Cowen Outperform
2020-02-24 Iniziato JP Morgan Overweight
2020-02-24 Iniziato Jefferies Buy
Mostra tutto

Black Diamond Therapeutics Inc Borsa (BDTX) Ultime notizie

pulisher
Jan 20, 2025

Barclays PLC Has $339,000 Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Jan 20, 2025
pulisher
Jan 15, 2025

Critical Comparison: Black Diamond Therapeutics (NASDAQ:BDTX) & Cardiol Therapeutics (NASDAQ:CRDL) - Defense World

Jan 15, 2025
pulisher
Jan 13, 2025

3 US Penny Stocks With Market Caps Under $200M - Simply Wall St

Jan 13, 2025
pulisher
Jan 13, 2025

Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 13, 2025
pulisher
Jan 12, 2025

Raymond James Predicts Up to ~930% Rally for These 2 ‘Strong Buy’ Stocks - Yahoo Finance

Jan 12, 2025
pulisher
Jan 10, 2025

Are Medical Stocks Lagging Aptevo Therapeutics (APVO) This Year? - Yahoo Finance

Jan 10, 2025
pulisher
Jan 08, 2025

BDTX stock touches 52-week low at $2.08 amid market challenges - Investing.com

Jan 08, 2025
pulisher
Jan 08, 2025

BDTX stock touches 52-week low at $2.08 amid market challenges By Investing.com - Investing.com South Africa

Jan 08, 2025
pulisher
Jan 08, 2025

Roche purchases shares in tender offer for Poseida Therapeutics, Inc. - Yahoo Finance

Jan 08, 2025
pulisher
Jan 07, 2025

Soleno Therapeutics, Inc. (NASDAQ:SLNO): When Will It Breakeven? - Yahoo Finance

Jan 07, 2025
pulisher
Jan 06, 2025

XORTX Adds Late Stage Gout Program to Pipeline - Yahoo Finance

Jan 06, 2025
pulisher
Jan 06, 2025

Geode Capital Management LLC Raises Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Jan 06, 2025
pulisher
Jan 06, 2025

Geode Capital Management LLC Grows Stock Holdings in BARK, Inc. (NYSE:BARK) - Defense World

Jan 06, 2025
pulisher
Jan 06, 2025

Barclays PLC Acquires 11,273 Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV) - Defense World

Jan 06, 2025
pulisher
Jan 06, 2025

Geode Capital Management LLC Buys 50,579 Shares of Design Therapeutics, Inc. (NASDAQ:DSGN) - Defense World

Jan 06, 2025
pulisher
Jan 05, 2025

Barclays PLC Has $339,000 Stock Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Jan 05, 2025
pulisher
Jan 01, 2025

Why Is Summit Therapeutics Inc. (SMMT) Among the Best Multibagger Stocks to Buy Right Now? - Yahoo Finance

Jan 01, 2025
pulisher
Dec 31, 2024

State Street Corp Buys 118,764 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Dec 31, 2024
pulisher
Dec 30, 2024

Black Diamond Therapeutics: Speculative Buy With Precision Oncology Catalysts (BDTX) - Seeking Alpha

Dec 30, 2024
pulisher
Dec 30, 2024

Barclays PLC Has $1.10 Million Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World

Dec 30, 2024
pulisher
Dec 29, 2024

Sarepta Therapeutics, Inc. (SRPT): Is This Gene Therapy Stock a Good Buy Right Now? - Yahoo Finance

Dec 29, 2024
pulisher
Dec 27, 2024

Analysts Expect Breakeven For Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Before Long - Yahoo Finance

Dec 27, 2024
pulisher
Dec 24, 2024

Will TG Therapeutics, Inc. (TGTX) Make You Rich In 2025? - Yahoo Finance

Dec 24, 2024
pulisher
Dec 23, 2024

Is Sarepta Therapeutics, Inc. (SRPT) the Best Performing Biotech Stock in 2024? - Yahoo Finance

Dec 23, 2024
pulisher
Dec 21, 2024

Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) biggest owners are retail investors who got richer after stock soared 17% last week - Yahoo Finance

Dec 21, 2024
pulisher
Dec 20, 2024

Charles Schwab Investment Management Inc. Boosts Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

BDTX stock touches 52-week low at $2.31 amid market challenges - Investing.com India

Dec 19, 2024
pulisher
Dec 18, 2024

Analytical Overview: Black Diamond Therapeutics Inc (BDTX)’s Ratios Tell a Financial Story - The Dwinnex

Dec 18, 2024
pulisher
Dec 18, 2024

Fmr LLC Makes New Investment in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Dec 18, 2024
pulisher
Dec 17, 2024

Akava Therapeutics, Inc. congratulates SAB Chair Dr. Hande Ozdinler, Founder Dr. Richard B. Silverman, and Dr. William Klein on their recent grant of $7.3 million from the National Institute on Aging to investigate AKV9 in neurodegenerative diseases - Yahoo Finance

Dec 17, 2024
pulisher
Dec 14, 2024

Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory - Yahoo Finance

Dec 14, 2024
pulisher
Dec 12, 2024

US Penny Stocks Spotlight: Information Services Group Among 3 Top Picks - Simply Wall St

Dec 12, 2024
pulisher
Dec 11, 2024

Black Diamond (BDTX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Dec 11, 2024
pulisher
Dec 11, 2024

Fmr LLC Decreases Stock Position in Mobileye Global Inc. (NASDAQ:MBLY) - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

MFA Financial, Inc. (NYSE:MFA) Shares Sold by Fmr LLC - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

BNP Paribas Financial Markets Purchases 111,027 Shares of Under Armour, Inc. (NYSE:UA) - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

Fmr LLC Has $15.49 Million Stake in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

MetLife Investment Management LLC Raises Stake in Smith-Midland Co. (NASDAQ:SMID) - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

BNP Paribas Financial Markets Raises Stake in RadNet, Inc. (NASDAQ:RDNT) - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

Fmr LLC Increases Position in AppFolio, Inc. (NASDAQ:APPF) - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

Fmr LLC Raises Stock Position in ADT Inc. (NYSE:ADT) - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

Charles Schwab Investment Management Inc. Sells 309,336 Shares of Unisys Co. (NYSE:UIS) - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

Oruka Therapeutics, Inc. (NASDAQ:ORKA) institutional investors have had a good week as stock gains 15% - Yahoo Finance

Dec 11, 2024
pulisher
Dec 10, 2024

Point72 Asset Management L.P. Takes $3.03 Million Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - MarketBeat

Dec 10, 2024
pulisher
Dec 06, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) has caught the attention of institutional investors who hold a sizeable 42% stake - Yahoo Finance

Dec 06, 2024
pulisher
Dec 05, 2024

The number of Black Fortune 500 CEOs is still abysmally low. A ‘shocking’ corporate DEI practice might be to blame, Stanford professor says - Yahoo Finance

Dec 05, 2024
pulisher
Dec 02, 2024

vTv Therapeutics to Participate in 7th Annual Evercore HealthCONx Conference - Yahoo Finance

Dec 02, 2024
pulisher
Nov 29, 2024

Vestal Point Capital LP Purchases 2,928,500 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - MarketBeat

Nov 29, 2024
pulisher
Nov 29, 2024

Gene and Cell Therapies Targeting CNS Disorders Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight - The Globe and Mail

Nov 29, 2024
pulisher
Nov 29, 2024

Gene and Cell Therapies Targeting CNS Disorders Treatment - openPR

Nov 29, 2024
pulisher
Nov 28, 2024

Breakeven On The Horizon For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) - Yahoo Finance

Nov 28, 2024

Black Diamond Therapeutics Inc Azioni (BDTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Capitalizzazione:     |  Volume (24 ore):